HANCE SCARBOROUGH lobbying for ALLIANCE FOR PHARMACY COMPOUNDING

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 18, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Lobbyists on this filing 2

MICHAEL TOMBERLIN

Previously held: Chief of Staff, Rep. Chip Cravaack, Chief of Staff, Rep., Louie Gohmert
THERESA REED

Previously held: Leg. Director for Multiple Members

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 3

HR 6509
SAFE Drugs Act of 2025
S 3794
SAFE Drugs Act of 2026
HR 5316
Drug Shortage Compounding Patient Access Act of 2025

Lobbying activity 3

Health Issues

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Pharmacy

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. Drug Shortages SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations

Budget/Appropriations

Issues Related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2026 Appropriations. SAFE Drugs Act HR 6509/S.3794 The Drug Shortage Compounding Patient Access Act HR 5316 FY27 Appropriations